Yizhe Liu

Yizhe Liu

Auto-generated profile, based on publicly available information

Yizhe Liu

Department of Neurosurgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Carbon
Verified
Journal Article
Closed access
XLXiuyi Lin
Xiuyi Lin
YLYizhe Liu
Yizhe Liu
HTHong Tan
Hong Tan
BZBiao Zhang
Biao Zhang

16 April 2020 in Journal of Materials Chemistry A
Verified
Journal Article
Closed access
PDF file
Yizhen ZhangYizhen Zhang
Yizhen Zhang
JHJue Hu
Jue Hu
CZChengxu Zhang
Chengxu Zhang
YLYizhe Liu
Yizhe Liu
MXMengyuan Xu
Mengyuan Xu
Michael K.H. LeungMichael K.H. Leung
Michael K.H. Leung
Electrocatalytic nitrogen fixation at room temperature and ambient pressure is considered to be one of the most energy-efficient and environmentally-friendly approaches to ammonia (NH3) production. The construction of efficient catalysts for the electrocatalytic nitrogen reduction reaction (NRR) remains a significant challenge. However, there have been no reports dedicated to non-noble bimetals on nitrogen-doped carbons as efficient NRR electrocatalysts, considered from either side of the theoretical volcano plot for the NRR. Herein, Mo–Co bimetallic nanoparticles anchored on nitrogen-doped porous carbon (Mo–Co/NC) are developed for the first time and serve as a cost-effective catalyst candidate for the NRR. In comparison to single-metallic Co/NC, a bimetallic Mo–Co/NC catalyst exhibits the enhanced activity and selectivity of NRR electrocatalysis with an ammonia yield of 89.8 μmol h−1 gcat. −1 and a faradaic efficiency of 13.5%, at a low operating potential of −0.10 V (vs. RHE) in 0.1 M Na2SO4. Moreover, the composite catalyst shows high electrochemical stability and selectivity during 50 000 s of NRR processing. The favorable NRR electrocatalytic activity of Mo–Co/NC could be ascribed to the synergistic effect of strongly adsorbed Mo and weakly adsorbed Co composite. This work provides a facile strategy towards the design of porous non-precious metallic electrocatalysts for efficient NRR under ambient conditions.

27 May 2020 in Energy & Environmental Materials
Verified
Journal Article
Open access
PDF file
XWXin Wu
Xin Wu
FQFeng Qi
Feng Qi
FLFengzhu Li
Fengzhu Li
XDXiang Deng
Xiang Deng
ZLZhen Li
Zhen Li
ZZZonglong Zhu
Zonglong Zhu
All‐inorganic perovskite solar cells (PVSCs) have drawn widespread attention for its superior thermal stability. Carbon‐based devices are promising to demonstrate excellent long‐term operational stability due to the hydrophobicity of carbon materials and the abandon of organic hole‐transporting materials (HTMs). However, the difficulty to control the crystallinity process and the poor morphology leads to serious non‐radiative recombination, resulting in low VOC and power conversion efficiency (PCE). In this article, the crystal formation process of all‐inorganic perovskites is controlled with a facile composition engineering strategy. By bromide incorporation, high‐quality perovskite films with large grain and fewer grain boundaries are achieved. As‐prepared perovskite films demonstrate longer carrier lifetime, contributing to lower energy loss and better device performance. Fabricated carbon‐based HTM‐free PVSCs with CsPbI2.33Br0.67 perovskite realized champion PCE of 12.40%, superior to 8.80% of CsPbI3‐based devices, which is one of the highest efficiencies reported for the carbon‐based all‐inorganic PVSCs to date. The high VOC of 1.01 V and FF of 70.98% indicate the significance of this composition engineering method. Moreover, fabricated carbon‐based devices exhibit excellent stability, and unencapsulated device retains over 90% of its initial efficiency under continuous one sun illumination for 250 h in N2 atmosphere and keeps ~84% of its original value after stored in ambient environment with RH 15–20% for 200 h. This work provides a facile way to fabricate high‐performance and stable carbon‐based all‐inorganic PVSCs.

20 April 2023 in Frontiers in Medicine
Verified
Journal Article
Open access
HLHongxin Li
Hongxin Li
CZCui Zhang
Cui Zhang
KZKai Zhang
Kai Zhang
YLYi-Zhe Liu
Yi-Zhe Liu
XPXiao-Xiao Peng
Xiao-Xiao Peng
QZQiang Zong
Qiang Zong
Background: The relationship between inflammatory bowel disease (IBD) and the risk of Parkinson’s Disease (PD) has been investigated in several epidemiological studies. However, the results of these studies were inconclusive and inconsistent. We evaluated the potential relationship between IBD and PD risk by a meta-analysis.Methods: Search the electronic databases PubMed, Embase and Cochrane databases from inception to November 30, 2022, to identify relevant studies that assess the risk of PD in patients with IBD. The cohort, cross-sectional, mendelian randomization and case-control studies that reported risk estimates of PD and IBD were included in our analysis. The random-effect model and fixed-effects model were used to calculate the summary relative risks (RRs) with 95% confidence intervals (CIs).Results: In total, 14 studies (nine cohort studies, two cross-sectional studies, two mendelian randomization studies and one case-control study) involving more than 13.4 million individuals were analyzed in our analysis. Our results suggested that the risk of PD in IBD patients is moderately increased, with the pooled RR was 1.17 (95% CI: 1.03–1.33, P = 0.019). Omit of any single study from this analysis had little effect on the combined risk estimate. No evidence of publication bias was found. In the subgroup analysis, the combined RR was 1.04 (95% CI: 0.96, 1.12, P = 0.311) for Crohn’s disease (CD), and 1.18 (95% CI: 1.06, 1.31, P = 0.002) for ulcerative colitis (UC). In addition, a significant association was identified in patients with IBD aged ≥ 60 years (RR = 1.22; 95% CI: 1.06–1.41, P = 0.007), but not in age < 60 years (RR = 1.19; 95% CI: 0.58–2.41, P = 0.639). Meanwhile, the meta-analysis results suggested a protective role for IBD medication use against PD development, with the RR was 0.88 (95% CI: 0.74, 1.04, P = 0.126).Conclusion: Our results indicated that patients with IBD had a moderately higher risk of PD compared to non-IBD individuals. Patients with IBD should be aware of the potential risks for PD, especially who were ≥ 60 years old.

1 March 2021 in Materials Today Energy
Verified
Journal Article
Closed access
YLY. Liu
Y. Liu
XWX. Wu
X. Wu
XGX. Guo
X. Guo
KLK. Lee
K. Lee
QSQ. Sun
Q. Sun
ZZZ. Zhu
Z. Zhu